Cerium oxide-graphene as the matrix for cholesterol sensor

Area of Science:

• Analytical Chemistry
• Materials Science
• Biotechnology

Background:

• Cholesterol detection is crucial for diagnosing various health conditions.
• Existing biosensors often face limitations in sensitivity, stability, and cost-effectiveness.
• Development of advanced materials is key to improving biosensor performance.

Purpose of the Study:

• To develop a simple, sensitive, and stable electrogenerated chemiluminescence (ECL) biosensor for cholesterol detection.
• To utilize cerium oxide-graphene (CeO(2)-graphene) composites as an efficient matrix for the ECL system.
• To investigate the potential of this biosensor as a low-cost, high-speed analytical method.

Main Methods:

• Preparation of CeO(2)-graphene composites by depositing CeO(2) onto graphene.
• Characterization of the composites using scanning electron microscopy.
• Assembly of the ECL biosensor and investigation of its surface, ECL behavior, and electrochemistry.
• Quantification of cholesterol using the luminol-hydrogen peroxide system catalyzed by CeO(2)-graphene.

Main Results:

• CeO(2)-graphene composites effectively catalyzed the luminol-H(2)O(2) ECL system, significantly amplifying the signal.
• The biosensor demonstrated excellent stability and a long operational lifetime due to the biocompatible microenvironment provided by CeO(2)-graphene.
• Cholesterol was quantified in a linear range from 12 μM to 7.2 mM with a low detection limit of 4.0 μM.
• The biosensor exhibited superior reproducibility, long-term stability, and selectivity.

Conclusions:

• The developed CeO(2)-graphene composite-based ECL biosensor is a highly sensitive and stable platform for cholesterol detection.
• This approach offers a promising alternative analytical method for cholesterol monitoring, characterized by its low cost and high speed.
• The findings highlight the potential of nanomaterial composites in advancing biosensor technology for clinical applications.